Surrey Clinical Research Centre achieves MHRA accreditation
17 June 2010
The Medicines and Healthcare products Regulatory Agency (MHRA)
has awarded the Surrey Clinical Research Centre (Surrey CRC) at the
University of Surrey standard accreditation for conducting clinical
pharmacology Phase I trials.
The accreditation scheme was introduced to improve the safety of
clinical research volunteers and assesses the capability of the
clinical research centre based on facilities, training and
experience of staff. The accreditation gives additional reassurance
and confidence that the Surrey CRC meets the highest of industry
clinical research standards.
Dr Julia Boyle, Director of Surrey CRC, said: "I am very proud to
announce the accreditation of the Surrey CRC by the MHRA. Our
accreditation success reflects the strong commitment of the
University of Surrey — and in particular the Surrey CRC team — to
excellence and high-quality research. The Surrey CRC is embedded in
an academic environment with international recognition for clinical
research. In addition to our academic strength, the accreditation
places us firmly alongside the best commercial clinical research
organisations in the UK."
The Surrey Clinical Research Centre has a particular emphasis on
sleep and human psychopharmacology. To date it has undertaken over
250 clinical trials including both volunteer and patient